B.Riley Sees Increasing Certainty for Secondary COVID Players Novavax (NVAX) and Altimmune (ALT)
Tweet Send to a Friend
B.Riley analyst Mayank Mamtani reiterated Buy ratings on Novavax (NASDAQ: NVAX) and Altimmune (NASDAQ: ALT) on the belief that there ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
